Home » Topics » BioWorld Science

BioWorld Science
RSS

J-TEC signs license agreement for low-cost manufacturing technology of CAR-T cells

June 25, 2018

FDA clears IND for pivotal trial of INP-104 for acute treatment of migraine

June 25, 2018

Prefusion F protein respiratory syncytial virus vaccine DS-Cav1 safe in first-in-human study

June 25, 2018

YH-25448 demonstrates promising antitumor activity in patients with EGFR T790M-positive NSCLC

June 25, 2018

Erytech refocuses development efforts with eryaspase

June 25, 2018

IMpower133 study of Tecentriq in extensive stage SCLC meets coprimary endpoints

June 25, 2018

City of Hope studies memory-enriched T cells in recurrent or refractory glioma

June 25, 2018

Ohara Pharmaceutical obtains certain rights to compound from PRISM Pharma

June 25, 2018

FDA awards orphan drug designation to PCS-499 for necrobiosis lipoidica

June 25, 2018

AZD-9567 shows better therapeutic ratio than prednisolone in vivo and in clinical setting

June 25, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Orexin OX2 receptor agonists disclosed in Vertex Pharmaceuticals patent
BioWorld Science
Vertex Pharmaceuticals Inc. has patented new macrocyclic sulfonamide orexin OX2 receptor agonists potentially useful for the treatment of amyotrophic lateral...